(CercleFinance.com) – UBS reaffirms its ‘buy’ recommendation on Ontex Group with a price target raised from 10 to 10.7 euros, a new target containing a potential increase of 18% for the title of the Belgian manufacturer of health products. ‘personal hygiene.
‘We continue to view Ontex as an attractive turnaround story,’ says the broker in the summary of its note, after the publication of results for the first quarter of 2024 marked by further sequential improvement.
Copyright © 2024 CercleFinance.com. All rights reserved.
The information and analyzes disseminated by Cercle Finance only constitute a decision-making aid for investors. Cercle Finance cannot be held responsible directly or indirectly following the use of information and analyzes by readers. It is recommended that any uninformed person consult a professional advisor before making any investment. This indicative information does not in any way constitute an inducement to sell or a solicitation to buy.
Did you like this article ? Share it with your friends using the buttons below.
